Astellas Pharma and Poseida Therapeutics have announced a strategic investment to support Poseida’s commitment to redefining cancer cell therapy. Under the terms of the agreement, Astellas will invest ...

Merck & Co – known as MSD outside the US and Canada – has signed a worldwide licensing deal worth up to $922.5m with Opko Health’s ModeX Therapeutics unit for its experimental Epstein-Barr virus (EBV) ...

Healthcare agency GCI Health has announced its expansion into the Middle East, with the new division set to be led by Kath Kerry (pictured above), president – Europe & Middle East. GCI Health Middle ...

German biotech company CureVac is planning to expand the protocols for its ongoing late-stage trials of its COVID-19 vaccine candidate CVnCoV to determine if the jab is effective against new virus ...

The UK confirmed its first two cases of coronavirus infection this morning, after the World Health Organization (WHO) declared the outbreak a global emergency yesterday. Few details are available ...

ThromboGenics has strengthened its senior leadership team with the appointment of Susan Schneider, who joins the Belgian biotech as its chief medical officer. Schneider has 16 years’ experience of ...

Google’s artificial intelligence unit has formed a pact with a London hospital to research the leading cause of blindness in the UK. It’s the first medical research project for DeepMind Health, which ...

A gene therapy for the eye disease retinal dystrophy has cleared a phase III trial, setting developer Spark Therapeutics on course to file for approval in 2016. The late-stage study of SPK-RPE65 was ...

Pfizer received a blow yesterday when a key European regulatory advisory committee declined to recommend Xeljanz as a treatment for rheumatoid arthritis (RA). The Committee for Medicinal Products for ...